New hope for tiny tummies: drug trial targets deadly infant gut disease
Disease control
Recruiting now
This study tests a new drug called ST266 in premature infants with necrotizing enterocolitis (NEC), a severe gut infection. The trial will include 36 babies and aims to see if the drug is safe and tolerable at two different doses. Researchers will also look for early signs that i…
Phase: PHASE1, PHASE2 • Sponsor: Noveome Biotherapeutics, formerly Stemnion • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC